Aydın Rodi Tosu

Aydın Rodi Tosu

Auto-generated profile, based on publicly available information

Aydın Rodi Tosu

Univ Hlth Sci Turkey, Istanbul Haseki Training & Res Hosp, Clin Cardiol, Istanbul, Turkiye

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in International Journal of Cardiology
Verified
Journal Article
Closed access
EIErkan İlhan
Erkan İlhan
MEMehmet Ergelen
Mehmet Ergelen
ÖSÖzer Soylu
Özer Soylu
RTRodi Tosu
Rodi Tosu
TGTolga Sinan Güvenç
Tolga Sinan Güvenç
TTTuna Tezel
Tuna Tezel

7 October 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
HBHalil ibrahim Biter
Halil ibrahim Biter
MKMuhsin Kalyoncuoğlu
Muhsin Kalyoncuoğlu
ATAydın Rodi Tosu
Aydın Rodi Tosu
Sinem CakalSinem Cakal
Sinem Cakal
ZAZiya Apaydın
Ziya Apaydın
MCMehmet Mustafa Can
Mehmet Mustafa Can
OBJECTIVE: The purpose of this study was to explore the efficacy of the triglyceride glucose (TyG) index on in-hospital mortality in nondiabetic coronavirus disease 2019 (COVID-19) patients with myocardial injury.METHODS: This was a retrospective study, which included 218 nondiabetic COVID-19 patients who had myocardial injury. The TyG index was derived using the following equation: log [serum triglycerides (mg/dL) xfasting blood glucose (mg/dL)/2].RESULTS: Overall, 49 (22.4%) patients died during hospitalization. Patients who did not survive had a higher TyG index than survivors. In multivariate Cox regression analysis, it was found that the TyG index was independently associated with in-hospital death. A TyG index cutoff value greater than 4.97 was predicted in-hospital death in nondiabetic COVID-19 patients with myocardial damage, with 82% sensitivity and 66% specificity. A pairwise evaluation of receiver operating characteristic (ROC) curves demonstrated that the TyG index (AUC: 0.786) had higher discriminatory performance than both triglyceride (AUC: 0.738) and fasting blood glucose (AUC: 0.660) in predicting in-hospital mortality among these patients. CONCLUSIONS: The TyG index might be used to identify high-risk nondiabetic COVID-19 patients with myocardial damage.

22 November 2022 in Journal of Cardiovascular and Thoracic Research
Verified
Journal Article
Closed access
PDF file
ATAydın Rodi Tosu
Aydın Rodi Tosu
TCTufan Cinar
Tufan Cinar
MKMuhsin Kalyoncuoğlu
Muhsin Kalyoncuoğlu
HBHalil İbRahim Biter
Halil İbRahim Biter
SÇSinem Çakal
Sinem Çakal
MCMehmet Mustafa Can
Mehmet Mustafa Can
Introduction: The focus of this research was to explore the link between CRP (C-reactive protein) /albumin ratio (CAR), a novel inflammatory response marker, and no-reflow (NR) phenomena in non-ST elevation myocardial infarction (non-STEMI) patients during percutaneous coronary intervention (PCI). Methods: The current study recruited 209 non-STEMI participants who underwent PCI. The patients were divided into two groups based on their post-intervention Thrombolysis in Myocardial Infarction (TIMI) flow grade; those with and without NR. Results: In all, 30 non-STEMI patients (6.9%) had NR after PCI. CAR values were substantially greater in the NR group. The CAR was identified to be a determinant of the NR (OR: 1.250, 95% CI: 1.033-1.513, P=0.02), although CRP and albumin were not independently related with NR in the multivariate analysis. In our investigation, low density lipoprotein-cholesterol levels and high thrombus burden were also predictors of the occurrence of NR. According to receiver operating characteristic curve evaluation, the optimal value of CAR was>1.4 with 60% sensitivity and 47% specificity in detecting NR in non-STEMI patients following PCI. Conclusion: To the best of knowledge, this is the first investigation to demonstrate that the CAR, a new and useful inflammatory marker, can be utilized as a predictor of NR in patients with non-STEMI prior to PCI.